"CD4-CD8 Ratio" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Ratio of T-LYMPHOCYTES that express the CD4 ANTIGEN to those that express the CD8 ANTIGEN. This value is commonly assessed in the diagnosis and staging of diseases affecting the IMMUNE SYSTEM including HIV INFECTIONS.
| Descriptor ID |
D016516
|
| MeSH Number(s) |
E01.370.225.500.195.107.595.500.150.160 E01.370.225.625.107.595.500.150.160 E05.200.500.195.107.595.500.150.160 E05.200.625.107.595.500.150.160 E05.242.195.107.595.500.150.160 G04.140.107.595.500.150.160 G09.188.105.595.500.150.160 G12.248
|
| Concept/Terms |
CD4-CD8 Ratio- CD4-CD8 Ratio
- CD4 CD8 Ratio
- CD4-CD8 Ratios
- T4-T8 Ratio
- T4 T8 Ratio
- T4-T8 Ratios
|
Below are MeSH descriptors whose meaning is more general than "CD4-CD8 Ratio".
Below are MeSH descriptors whose meaning is more specific than "CD4-CD8 Ratio".
This graph shows the total number of publications written about "CD4-CD8 Ratio" by people in this website by year, and whether "CD4-CD8 Ratio" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 2 | 2 |
| 2005 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2015 | 0 | 2 | 2 |
| 2017 | 6 | 11 | 17 |
| 2018 | 1 | 7 | 8 |
| 2019 | 0 | 6 | 6 |
| 2020 | 0 | 6 | 6 |
| 2021 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "CD4-CD8 Ratio" by people in Profiles.
-
Analysis of Lymphocyte Subpopulations and Cytokines in COVID-19-Associated Pneumonia and Community-Acquired Pneumonia. J Immunol Res. 2021; 2021:6657894.
-
Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV. Lancet HIV. 2021 06; 8(6):e317-e318.
-
The effect of age on the clinical and immune characteristics of critically ill patients with COVID-19: A preliminary report. PLoS One. 2021; 16(3):e0248675.
-
The role of probiotics in coronavirus disease-19 infection in Wuhan: A retrospective study of 311 severe patients. Int Immunopharmacol. 2021 Jun; 95:107531.
-
Sex differences in immune responses to SARS-CoV-2 in patients with COVID-19. Biosci Rep. 2021 01 29; 41(1).
-
Risk factors associated with 28-day all-cause mortality in older severe COVID-19 patients in Wuhan, China: a retrospective observational study. Sci Rep. 2020 12 22; 10(1):22369.
-
Experience of SARS-CoV-2 infection in two kidney transplant recipients living with HIV-1 infection. Transpl Infect Dis. 2021 Apr; 23(2):e13500.
-
CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study. Viruses. 2020 11 09; 12(11).
-
Risk factors for redetectable positivity in recovered COVID-19 children. Pediatr Pulmonol. 2020 12; 55(12):3602-3609.
-
Factors associated with clinical outcomes in patients with Coronavirus Disease 2019 in Guangzhou, China. J Clin Virol. 2020 12; 133:104661.